Advertisement

Payer

UnitedHealth Group CEO David Wichmann purchased a record 20,000 UnitedHealth shares May 3, according to a filing with the Securities and Exchange Commission.

While Pfizer gained approval for its drug tafamidis to treat a rare and fatal heart disease, whether insurers and employers will cover the drug's list price — $225,000 — remains uncertain, according to Forbes contributor Bruce Japsen.

Advertisement

Cigna's U.S. privacy officer and lead cybersecurity counsel left the company for a new position, according to Bloomberg Law.

Advertisement